U.S. EDITIONTHEWEEKLYOBSERVER.COM

HOME  /  WORLD  /  STOCKHOLM

WORLD · SCIENCE

Nobel Judges Crack a 100-Year Riddle — Two Chemists Share $1.2M Prize for 'Mirror Molecule' Breakthrough

The Royal Swedish Academy of Sciences awarded the 2026 Nobel Prize in Chemistry to France's Henri Kagan and Japan's Kenso Soai, honoring decades of work that let chemists finally build one-handed molecules on command.

OS

BY OBSERVER STAFF

The Weekly Observer

OCT 7, 2026 · 3 MIN READ
fXinEMAIL
Nobel Judges Crack a 100-Year Riddle — Two Chemists Share $1.2M Prize for 'Mirror Molecule' Breakthrough
File photo: laboratory glassware and flasks (illustrative). Photo via Pexels.

Stockholm handed out science's biggest prize Wednesday to two chemists who spent their careers chasing a problem that dates back more than a century: how to make nature's "handed" molecules point just one way. The 2026 Nobel Prize in Chemistry went jointly to Henri B. Kagan, 95, of Universite Paris-Sud in France, and Kenso Soai, 76, of the Tokyo University of Science in Japan.

The Royal Swedish Academy of Sciences cited the pair "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis" — in plain terms, cracking the chemistry of chirality, the property that makes a molecule and its mirror image behave like a left and right hand. They look alike, but they don't line up, and in the body that difference can mean the gap between a working drug and a dangerous one.

From a lab discovery to safer medicine

Kagan's breakthrough came in 1986, when he found a way to nudge a chemical reaction so it produced far more of one mirror-image molecule than its chemists had any right to expect from their starting materials. Seventeen years later, Soai pushed the idea to its limit, engineering a reaction that built a chiral molecule entirely from non-chiral ingredients — something that, outside of life itself, no one had ever managed to do.

Before this work, many pharmaceuticals were sold as racemates, 50-50 mixtures of both mirror-image forms, even though only one version typically does the job a drug is meant to do, according to the reporting on the award. More than half of all clinically used drugs are chiral, and the methods pioneered by Kagan and Soai gave the pharmaceutical industry a way to manufacture the correct, single form reliably — reducing side effects and improving safety in everything from heart medication to painkillers.

Nobel Committee member Peter Somfai didn't hide his admiration for Soai's signature result, calling it, according to Forbes's coverage of the announcement, nothing less than "the coolest experiment in organic chemistry."

"IT'S ONE OF THE MOST EXCITING DAYS OF MY LIFE. I'M VERY GLAD TO SHARE THE AWARD WITH PROFESSOR KAGAN," Soai said by phone from Hiroshima, Japan, as the ceremony unfolded at the Karolinska Institutet in Stockholm.

The two chemists will split the prize purse of 12 million Swedish kronor, roughly $1.2 million, along with the traditional gold medal and diploma. Kagan and Soai never formally collaborated, but the Academy treated their findings as two halves of the same discovery — one showing a reaction could be coaxed toward one mirror-image form, the other proving a reaction could create that imbalance from scratch.

Wednesday's announcement capped a Nobel week that began Monday with the physics prize going to Belgian-American physicist Francis Halzen for his work detecting cosmic neutrinos with the IceCube Observatory at the South Pole. The literature and peace prizes are set to follow later this week, with the economics prize closing out the cycle on October 12.

SHARE THIS STORY